Christoffer Rosenblad Appointed as CEO of XVIVO
Nov 30 (Reuters) - Xvivo Christoffer Rosenblad appointed as CEO of XVIVO. * Xvivo Christoffer has had the role of acting CEO since September 27, 2022 and will take up his permanent role immediately
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength